<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03163914</url>
  </required_header>
  <id_info>
    <org_study_id>Vasopressor</org_study_id>
    <nct_id>NCT03163914</nct_id>
  </id_info>
  <brief_title>Effect of Vasopressors on Spinal Anaesthesia Induced Hypotension</brief_title>
  <official_title>Comparison of the Effect of Epinephrine, Norepinephrine and Phenylephrine on Spinal Anesthesia Induced Hypotension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cukurova University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cukurova University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      96 pregnant patients will be enrolled in this study. Participants will divide in to 3 groups.
      Spinal anaesthesia will perform with 5% marcain heavy 2 ml+20 microgram fentanyl to the all
      patients. After performed spinal anaesthesia, vasopressor infusion will be started
      intravenously. Epinephrine will prepare 5 mg/ml and infusion rate will adjust 30 ml/h for
      Group E. Norepinephrine will prepare 5 mg/ml and infusion rate will adjust 30 ml/h for Group
      NE. Phenylephrine will prepare 100 microg/ml and infusion rate will adjust 30 ml/h for Group
      P. If systolic blood pressure decrease 20% of basal value or below to 100 mmHg, bolus
      ephedrine will apply intravenously (IV). If heart rate will decrease 60 beat per min or 20%
      of basal value, atropine will apply IV.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approved informed consent, 96 pregnant (term) patients with American society of
      anaesthesiologist (ASA) physiological status I-II will include this prospective, randomized
      clinical study. For randomisation of participants, computerized randomisation programme will
      use and they will divide into 3 groups. Basal value of systolic blood pressure(SBP) and heart
      rate (HR) will calculate with mean of the measure of 3 time SBP and HR before spinal
      anaesthesia. Spinal anaesthesia will perform with 5% marcain heavy 2 ml+20 microgram fentanyl
      at the point of lumbar 3-4 or 4-5 interspinous space to the all patients. After performed
      spinal anaesthesia, vasopressor infusion will start intravenously. Epinephrine,
      norepinephrine and phenylephrine will use for vasopressor infusion. Epinephrine will prepare
      5 mg/ml and infusion rate will adjust 30 ml/h for Group E. Norepinephrine will prepare 5
      mg/ml and infusion rate will adjust 30 ml/h for Group NE. Phenylephrine will prepare 100
      microg/ml and infusion rate will adjust 30 ml/h for Group P. If systolic blood pressure
      decrease 20% of basal value or below to 100 mmHg, bolus ephedrine will apply intravenously
      (IV) for rescue drug. If heart rate will decrease 60 beat per min or 20% of basal value,
      atropine will apply IV.

      At the end of the study all collected data will use for statistically analysis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 19, 2017</start_date>
  <completion_date type="Actual">April 24, 2018</completion_date>
  <primary_completion_date type="Actual">April 24, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Partipicants and care providers will not known which medication will apply.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Requirement of ephedrine</measure>
    <time_frame>At the time from start of vasopressor infusion till the end of surgery. The time frame is approximately 1 hour, peroperatively.</time_frame>
    <description>If systolic blood pressure decrease 20% of basal value or below 100 mmHg, ephedrine will apply. Totally ephedrine requirements will calculate end of the surgery.</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">160</enrollment>
  <condition>Spinal Anesthetics Causing Adverse Effects in Therapeutic Use</condition>
  <arm_group>
    <arm_group_label>Epinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Epinephrine will prepare as 5µg/ ml and epinephrine infusion rate will adjust 30 ml/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Norepinephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Norepinephrine will prepare as 5µg/ ml and epinephrine infusion rate will adjust 30 ml/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Phenylephrine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Phenylephrine will prepare as 100 µg/ ml and phenylephrine infusion rate will adjust 30 ml/h.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline infusion will apply at equivalent volume till the surgical operation</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Epinephrine</intervention_name>
    <description>Epinephrine infusion rate will adjust 30 ml/h (5µg/ ml )</description>
    <arm_group_label>Epinephrine</arm_group_label>
    <other_name>group I</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Norepinephrine</intervention_name>
    <description>Norepinephrine infusion rate will adjust 30 ml/h (5µg/ ml )</description>
    <arm_group_label>Norepinephrine</arm_group_label>
    <other_name>group II</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Phenylephrine</intervention_name>
    <description>Phenylephrine infusion rate will adjust 30 ml/h (100µg/ ml )</description>
    <arm_group_label>Phenylephrine</arm_group_label>
    <other_name>group III</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>saline infusion will apply till the end of the surgery</description>
    <arm_group_label>Control</arm_group_label>
    <other_name>group IV</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ASA I-II physical status

          -  Pregnant patients

          -  Full term pregnant

        Exclusion Criteria:

          -  ASA III-IV physical status

          -  Emergency status

          -  Heart disease

          -  Hypertension

          -  Body mass index&gt;25
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>pregnant patients</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hakkı Ünlügenç</last_name>
    <role>Study Director</role>
    <affiliation>Cukurova University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Çukurova University Balcalı Hospital</name>
      <address>
        <city>Adana</city>
        <zip>01380</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2017</study_first_submitted>
  <study_first_submitted_qc>May 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 23, 2017</study_first_posted>
  <last_update_submitted>April 24, 2018</last_update_submitted>
  <last_update_submitted_qc>April 24, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cukurova University</investigator_affiliation>
    <investigator_full_name>ebru biricik</investigator_full_name>
    <investigator_title>Dr</investigator_title>
  </responsible_party>
  <keyword>vasopressor</keyword>
  <keyword>spinal anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
    <mesh_term>Epinephrine</mesh_term>
    <mesh_term>Racepinephrine</mesh_term>
    <mesh_term>Phenylephrine</mesh_term>
    <mesh_term>Oxymetazoline</mesh_term>
    <mesh_term>Norepinephrine</mesh_term>
    <mesh_term>Epinephryl borate</mesh_term>
    <mesh_term>Vasoconstrictor Agents</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

